US2024025929A1PendingUtilityA1
Methods and devices for ultrasensitive direct detection of microorganisms
Est. expiryApr 16, 2039(~12.8 yrs left)· nominal 20-yr term from priority
C07F 9/1411C12Q 1/6844C12Q 1/6888C12Q 2527/137C12Q 2523/10C12Q 2527/119C12Q 1/689C12Q 1/6895C12Q 1/70C12Q 1/6806
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure generally relates to the field of ultrasensitive microbial pathogen detection and identification utilizing genomic sequence recognition.
Claims
exact text as granted — not AI-modified1 . A composition consisting essentially of:
a magnesium salt; a buffering agent; water; and a compound of Formula 1:
wherein R 1 is selected from the group consisting of optionally substituted, branched or unbranched, saturated or unsaturated C 1 -C 8 aliphatic; optionally substituted, saturated or unsaturated C 3 -C 14 carbocyclic; optionally substituted, saturated or unsaturated 3-8 membered heterocyclic; optionally substituted, branched or unbranched, saturated or unsaturated ((R a ) q —(C═O)—(R a ) q ) p ; optionally substituted C 6 -C 14 aryl; and optionally substituted 3-8 membered heteroaryl; and/or any suitable combinations thereof;
wherein R 2 is selected from the group consisting of hydrogen; optionally substituted, branched or unbranched, saturated or unsaturated C 1 -C 28 aliphatic; optionally substituted, branched or unbranched, saturated or unsaturated —(R b —(O—R b ) n —O—R b ) p ; optionally substituted, branched or unbranched, saturated or unsaturated —(R b —(O—R b ) n —NH—R b ) p ; optionally substituted, branched or unbranched, saturated or unsaturated —(R b —(O—R b —O) n —S—R b ) p ; optionally substituted, branched or unbranched, saturated or unsaturated —(R b —(S—R b ) n —S—R b ) p ; optionally substituted C 6 -C 14 aryl; optionally substituted 3-8 membered heteroaryl; optionally substituted, saturated or unsaturated C 3 -C 14 carbocyclic; optionally substituted, saturated or unsaturated 3-8 membered heterocyclic; optionally substituted, branched or unbranched, saturated or unsaturated —(C═O)—(R b ); optionally substituted, branched or unbranched, saturated or unsaturated —((R a ) q —O—(R a ) q ) p —; optionally substituted, branched or unbranched, saturated or unsaturated —((R a ) q —NH—(R a ) q ) p —; optionally substituted, branched or unbranched, saturated or unsaturated —((R a ) q —N(R a )—(R a ) q ) p —; and optionally substituted, branched or unbranched, saturated or unsaturated —((R a ) q —S—(R a ) q ) p —; and/or any suitable combinations thereof;
wherein each occurrence of R a is independently C 1 -C 8 aliphatic or C 6 -C 14 aryl;
wherein each occurrence of R b is independently C 1 -C 15 aliphatic or C 6 -C 14 aryl;
wherein each occurrence of subscript q is independently an integer between 0 and 1, inclusive;
wherein each occurrence of subscript p is independently an integer between 1 and 6, inclusive; and
wherein each occurrence of subscript n is independently an integer between 0 and 14, inclusive.
2 . The composition of claim 1 , further comprising blood.
3 . The composition of claim 2 , wherein the composition comprises between 20% and 60%, inclusive, of the blood by volume.
4 . The composition of claim 2 , wherein the blood comprises microbial cells.
5 . A kit, comprising:
the composition of claim 1 ; and an anion-exchanger.
6 . The kit of claim 5 , wherein the kit further comprises microparticles.
7 . The kit of claim 5 , wherein the anion-exchanger comprises microparticles.
8 . The kit of claim 5 , wherein the anion-exchanger comprises magnetizable, electro-reactive microparticles.
9 . The kit of claim 5 , further comprising a composition comprising cell lysis reagents that allow for the lysis of microbial cells.
10 . The kit of claim 5 , further comprising a fluidic device.
11 . The kit of claim 5 , wherein the buffering agent comprises a polar small molecule and/or an inorganic salt.
12 . The kit of claim 5 , wherein the magnesium salt comprises an inorganic counter ion.
13 . The kit of claim 5 , wherein the magnesium salt is selected from the group consisting of MgCl 2 , MgCO 3 , MgSO 4 , and MgBr 2 .
14 . The kit of claim 5 , wherein R 2 is selected from the group consisting of optionally substituted, branched or unbranched, saturated or unsaturated C 1 -C 28 aliphatic; optionally substituted, branched or unbranched, saturated or unsaturated —(R b —(O—R b ) n —O—R b ) p ; optionally substituted, branched or unbranched, saturated or unsaturated —(R b —(O—R b ) n —NH—R b ) p ; optionally substituted, branched or unbranched, saturated or unsaturated —(R b —(O—R b —O) n —S—R b ) p ; optionally substituted, branched or unbranched, saturated or unsaturated —(R b —(S—R b ) n —S—R b ) p ; optionally substituted C 6 -C 14 aryl; optionally substituted 3-8 membered heteroaryl; optionally substituted, saturated or unsaturated C 3 -C 14 carbocyclic; optionally substituted, saturated or unsaturated 3-8 membered heterocyclic; optionally substituted, branched or unbranched, saturated or unsaturated —(C═O)—(R b ); optionally substituted, branched or unbranched, saturated or unsaturated —((R a ) q —O—(R a ) q ) p —; optionally substituted, branched or unbranched, saturated or unsaturated —((R a ) q —NH—(R a ) q ) p —; optionally substituted, branched or unbranched, saturated or unsaturated —((R a ) q —N(R a )—(R a ) q ) p —; and optionally substituted, branched or unbranched, saturated or unsaturated —((R a ) q —S—(R a ) q ) p —; and/or any suitable combinations thereof;
wherein each occurrence of R a is independently C 1 -C 8 aliphatic or C 6 -C 14 aryl;
wherein each occurrence of R b is independently C 1 -C 15 aliphatic or C 6 -C 14 aryl;
wherein each occurrence of subscript q is independently an integer between 0 and 1, inclusive;
wherein each occurrence of subscript p is independently an integer between 1 and 6, inclusive; and
wherein each occurrence of subscript n is independently an integer between 0 and 14, inclusive.
15 . The kit of claim 5 , wherein R 1 is independently selected from the group consisting of optionally substituted, branched or unbranched C 1 -C 8 alkyl; optionally substituted, branched or unbranched C 2 -C 8 alkenyl; and optionally substituted, branched or unbranched C 2 -C 8 alkynyl.
16 . The kit of claim 5 , wherein R 1 is optionally substituted, branched or unbranched C 1 -C 8 alkyl.
17 . The kit of claim 5 , wherein R 2 is independently selected from the group consisting of optionally substituted, branched or unbranched C 1 -C 28 alkyl and optionally substituted, branched or unbranched C 2 -C 28 alkenyl.
18 . The kit of claim 5 , wherein the compound of Formula 1 is selected from the group consisting of:
29 . The kit of claim 5 , wherein the compound of Formula 1 is
20 . The kit of claim 5 , wherein the pH has a value of between 8 and 11.5, inclusive.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.